IFS Advisors’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$968 Buy
+6
New +$1K ﹤0.01% 428

Other funds holding AZN

IFS Advisors's AZN Position: Q3 2026 in Review

IFS Advisors opened a new position in AstraZeneca (AZN) in Q3 2026: 6 shares worth $968. The stake represents ﹤0.01% of the portfolio and ranks #428 among its holdings.

1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • IFS Advisors held 6 shares of AstraZeneca worth $968 as of Q3 2026.
  • AstraZeneca was a new IFS Advisors position in Q3 2026.
  • AstraZeneca made up ﹤0.01% of IFS Advisors's portfolio in Q3 2026, its #428 holding.
  • 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on IFS Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.